"State laws matter." -- Patricia Logan-Greene, PhD, of the State University of New York at Buffalo, on an analysis that found ...

Called enpatoran, the agent targets the Toll-like receptor (TLR) species 7 and 8. Some 50%-60% of patients with systemic ...

BARCELONA -- The oral drug deucravacitinib (Sotyktu) passed what is probably its final test as a treatment for psoriatic ...

Wade, Medicaid expansion, marijuana decriminalization, and the rights of same-sex couples prior to Obergefell v. Hodges. Now, ...

Cuts to Medicaid and other federal health programs proposed in President Donald Trump's budget plan would rapidly push more ...

HHS Secretary Robert F. Kennedy Jr. said in April that he plans to tell medical schools to teach nutrition or risk losing ...

At their annual meeting, American Medical Association (AMA) delegates passed a resolution calling for a Senate investigation ...

Note that some links may require registration or subscription. Spinach, strawberries, kale, and grapes top a new "dirty dozen ...

Subsequent studies by other investigators confirmed those early results, ultimately leading to the FDA approval of ...

Sustained remission at 10 years was more common as well among the patients starting anti-TNFs right away, Toyoda told ...

Telomeres are protective caps at the end of chromosomes. They shorten each time cells divide, reflecting cumulative ...

BARCELONA -- A novel antibody-based drug targeting the CD40 ligand helped close to half of patients with treatment-refractory ...